AbbVie

Aktienkurs
229.50
Täglich Wechseln
4.69 2.09%
Monatlich
3.95%
Jährlich
12.46%
Q1 Prognose
217.84




Ebit Veränderung Datum
AbbVie USD 5.81B 4.36B 2025-12
Abbott USD 2.54B 358M 2025-12
ALKERMES USD 89.08M 3.9M 2025-09
Amgen USD 3.96B 464M 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
Biogen USD 659.6M 157M 2025-09
BioMarin Pharmaceutical USD 198.39M 230.08M 2025-12
Bristol-Myers Squibb USD 3.47B 567M 2025-12
Coherus Biosciences USD -45.43M 3.19M 2025-03
Eisai JPY 20.03B 6.36B 2025-12
Eli Lilly USD 8.99B 1.57B 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Infinity Pharmaceuticals USD -10.12M 1.39M 2023-06
J&J USD 5.11B 2.3B 2025-12
Medtronic USD 1.74B 40M 2025-12
Merck USD 6.24B 1.32B 2025-12
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
Novartis USD -9.19B 13.87B 2025-06
Pacira USD 13.15M 2.92M 2025-09
Perrigo USD 93.4M 37.8M 2025-09
Pfizer USD 4.65B 71M 2025-12
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Roche Holding CHF 9.56B 2.1B 2025-12
Sanofi EUR 1.7B 2.17B 2025-12
UCB EUR 502M 168M 2024-12
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
United Therapeutics USD 389.3M 112.4M 2025-09
Vertex Pharmaceuticals USD 1.26B 24.5M 2025-12
Zoetis USD 835M 140M 2025-12


AbbVie - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.